1. Characterization of murine monoclonal antibodies to the tat protein from human immunodeficiency virus type 1
- Author
-
Christine Debouck, W. J. A. Krone, N. Appleby, Jaap Goudsmit, P. Schammel, D. A. Brake, R. H. Meloen, and Other departments
- Subjects
medicine.drug_class ,Blotting, Western ,Molecular Sequence Data ,Immunology ,Cell ,Peptide ,Biology ,Monoclonal antibody ,Microbiology ,Epitope ,Virus ,Epitopes ,Western blot ,Virology ,medicine ,Amino Acid Sequence ,chemistry.chemical_classification ,medicine.diagnostic_test ,Antibodies, Monoclonal ,Molecular biology ,In vitro ,medicine.anatomical_structure ,Pepscan ,chemistry ,Insect Science ,Gene Products, tat ,HIV-1 ,Trans-Activators ,tat Gene Products, Human Immunodeficiency Virus ,Oligopeptides ,Research Article - Abstract
A panel of murine monoclonal antibodies (MAbs) to the human immunodeficiency virus type 1 trans-activator tat protein were characterized. The anti-tat MAbs were mapped to the different domains of the tat protein by Western blot (immunoblot) and Pepscan analyses. One-half of the MAbs tested mapped to the amino-terminal proline-rich region, and one-third of the MAbs tested mapped to the lysine-arginine-rich region of tat. The individual MAbs were tested for inhibition of tat-mediated trans activation, using a cell-based in vitro assay system. MAbs which mapped to the amino-terminal region of the tat protein demonstrated the highest degree of inhibition, whereas MAbs reactive to other portions of the molecule exhibited a less pronounced effect on tat function.
- Published
- 1990
- Full Text
- View/download PDF